Literature DB >> 7913831

Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes.

S V Balasubramanian1, R M Straubinger.   

Abstract

Taxol (paclitaxel) is a diterpenoid anticancer agent undergoing intensive human clinical evaluation. The poor aqueous solubility of taxol necessitates administration in excipients causing a variety of adverse effects, including anaphylactoid hypersensitivity reactions. Recently, taxol has been formulated in better-tolerated drug carriers such as liposomes. We investigated the conformation of taxol and the interaction of taxol with dipalmitoylphosphatidylcholine (DPPC) liposomes using fluorescence, circular dichroism, differential scanning calorimetry, fluorescence polarization, and X-ray diffraction. The conformation of taxol in DPPC membranes was similar to that observed in nonpolar solvents such as chloroform. Taxol was found to partition into the bilayer, perturbing the hydrocarbon chain conformation. The taxol C13 side chain was found to be fluorescent, and it displays an environment-sensitive shift in emission spectrum; taxol fluorescence was used to confirm the insertion of the drug into the bilayer. Taxol induces a broadening of the DPPC phase transition, and the location of the drug in the bilayer depends on drug concentration. Incorporation of taxol affects other physical properties of the bilayer such as the lipid order parameter, and this fluidizing effect was also observed upon incorporation of taxol in biological membranes isolated from basolateral plasma membranes of rat liver. These studies demonstrate that taxol incorporated into liposomes penetrates into the acyl chain domain of the bilayer and alters the physical properties of both artificial and biological membranes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913831     DOI: 10.1021/bi00196a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.

Authors:  S Ali; S Minchey; A Janoff; E Mayhew
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Influence of cholesterol on liposome stability and on in vitro drug release.

Authors:  Maria-Lucia Briuglia; Chiara Rotella; Amber McFarlane; Dimitrios A Lamprou
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

3.  Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic Liposomes.

Authors:  Jasmin Monpara; Chryso Kanthou; Gillian M Tozer; Pradeep R Vavia
Journal:  Pharm Res       Date:  2018-03-08       Impact factor: 4.200

4.  Fluorescence anisotropy, FT-IR spectroscopy and 31-P NMR studies on the interaction of paclitaxel with lipid bilayers.

Authors:  Anand Babu Dhanikula; Ramesh Panchagnula
Journal:  Lipids       Date:  2008-05-06       Impact factor: 1.880

5.  Comparison of two pharmacodynamic transduction models for the analysis of tumor therapeutic responses in model systems.

Authors:  Jun Yang; Donald E Mager; Robert M Straubinger
Journal:  AAPS J       Date:  2009-11-10       Impact factor: 4.009

6.  Pharmacokinetics of paclitaxel-containing liposomes in rats.

Authors:  Gerald J Fetterly; Robert M Straubinger
Journal:  AAPS PharmSci       Date:  2003-11-21

7.  Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging.

Authors:  Hongtao Chen; Sungwon Kim; Li Li; Shuyi Wang; Kinam Park; Ji-Xin Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-29       Impact factor: 11.205

8.  Distinct solubility and cytotoxicity regimes of paclitaxel-loaded cationic liposomes at low and high drug content revealed by kinetic phase behavior and cancer cell viability studies.

Authors:  Victoria M Steffes; Meena M Murali; Yoonsang Park; Bretton J Fletcher; Kai K Ewert; Cyrus R Safinya
Journal:  Biomaterials       Date:  2017-08-17       Impact factor: 12.479

Review 9.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

10.  Highly stable, ligand-clustered "patchy" micelle nanocarriers for systemic tumor targeting.

Authors:  Zhiyong Poon; Jung Ah Lee; Shenwen Huang; Richard J Prevost; Paula T Hammond
Journal:  Nanomedicine       Date:  2010-09-23       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.